Vimarsana
Biggest News Aggregation in the World

Caroline Bergmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Caroline Bergmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Caroline Bergmann Today - Breaking & Trending Today

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) -April 08, 2024 at 01:02 am EDT - Vimarsana News

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) -April 08, 2024 at 01:02 am EDT

EQS-News: Newron Pharmaceuticals S.p.A. / Key word: Study results Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual...

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) | Region - Vimarsana News

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) | Region

MILAN--(BUSINESS WIRE)--Apr 8, 2024--

Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS) - Vimarsana News

Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

EQS-News: Newron Pharmaceuticals S.p.A. / Key word: Study results Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia...

Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenam - Vimarsana News

Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenam

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): StudyNewron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide 29.12.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Newron completes enrollment of schizophrenia patie...

Newron Completes Enrollment of Schizophrenia Patients in Potentially Pivotal Study 008A With Evenamide - Vimarsana News

Newron Completes Enrollment of Schizophrenia Patients in Potentially Pivotal Study 008A With Evenamide

MILAN--(BUSINESS WIRE)--Dec 29, 2023--